Written by The Gene Panel Market is expanding as targeted genomic testing becomes increasingly important in precision medicine, oncology, hereditary disease screening, and pharmacogenomics. MRFR values the global market at USD 3.56 billion in 2025 and projects it to reach USD 14.03 billion by 2035. The market is benefiting from the shift from single-gene testing toward next-generation sequencing panels capable of examining multiple genes in a single workflow.
Gene panels are being adopted across hospitals, clinics, diagnostic laboratories, and research environments. Test kits accounted for 60.05% of market revenue in 2025, while amplicon-based approaches represented 65.46% of the market. Cancer risk assessment was the largest application, accounting for 52.45%, reflecting the growing role of multi-gene testing in hereditary and oncology-related diagnostics.
The market is also moving toward integrated genomic workflows that combine sequencing instruments, reagents, bioinformatics, and clinical reporting. Falling sequencing costs, improved throughput, AI-supported variant interpretation, and growing access to genomic testing are helping expand the use of gene panels. These developments are making targeted genomic analysis increasingly relevant beyond major academic medical centers and into community healthcare settings.
Discover emerging opportunities with in-depth research reports:
US Laboratory Chemicals Market Outlook
China Laxatives Market Analysis
GCC Women’s Healthcare Market Distribution